(ESNT) Essent - NYSE
Sector: Financial Services | Industry: Insurance - Specialty | Exchange: NYSE (USA) | Market Cap: 5.494m USD | Total Return: 0% in 12m
Avg Turnover: 46.5M
EPS Trend: 84.8%
Qual. Beats: 0
Rev. Trend: 89.8%
Qual. Beats: 0
Warnings
Choppy
Tailwinds
No distinct edge detected
Essent Group Ltd. (ESNT) is a Bermuda-based holding company that, through its subsidiaries, provides private mortgage insurance and reinsurance, as well as title insurance and settlement services, to mortgage lenders, borrowers, and investors in the United States. The company operates through two reporting segments: Mortgage Insurance and Reinsurance.
Its mortgage insurance offerings include primary, pool, and master policy products. In addition, Essent provides information technology maintenance and development services, customer support, underwriting consulting to third-party reinsurers, contract underwriting, and credit risk management products. The company also offers title insurance and settlement services, including title insurance underwriting.
Essents customers include originators of residential mortgage loans, such as regulated depository institutions, mortgage banks, credit unions, and other lenders. The company was founded in 2008 and is headquartered in Hamilton, Bermuda.
Private mortgage insurance generally protects lenders against losses from borrower defaults, and is typically required for residential loans with down payments below 20%, making issuers like Essent directly exposed to U.S. housing finance and credit cycles. Essent is classified under the Financials sector within the Commercial & Residential Mortgage Finance sub-industry.
- U.S. mortgage origination volumes drive insurance-in-force growth
- Persistency rises as homeowners delay refinancing amid higher rates
- Share buybacks accelerate capital return as book value grows
| Net Income: 686.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -1.03 > 1.0 |
| NWC/Revenue: 444.1% < 20% (prev 446.1%; Δ -2.06% < -1%) |
| CFO/TA 0.11 > 3% & CFO 826.5m > Net Income 686.3m |
| Net Debt (-5.68b) to EBITDA (859.4m): -6.61 < 3 |
| Current Ratio: 5.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (94.6m) vs 12m ago -9.02% < -2% |
| Gross Margin: 87.08% > 18% (prev 92.10%; Δ -5.02% > 0.5%) |
| Asset Turnover: 17.42% > 50% (prev 18.02%; Δ -0.60% > 0%) |
| Interest Coverage Ratio: 26.13 > 6 (EBIT TTM 854.3m / Interest Expense TTM 32.7m) |
| A: 0.75 (Total Current Assets 6.88b - Total Current Liabilities 1.16b) / Total Assets 7.57b |
| B: 0.71 (Retained Earnings 5.40b / Total Assets 7.57b) |
| C: 0.12 (EBIT TTM 854.3m / Avg Total Assets 7.39b) |
| D: 3.04 (Book Value of Equity 5.70b / Total Liabilities 1.87b) |
| Altman-Z'' = 11.25 = AAA |
| DSRI: 2.00 (Receivables 189.0m/95.4m, Revenue 1.29b/1.30b) |
| GMI: 1.06 (GM 92.10% / 87.08%) |
| AQI: 1.25 (AQ_t 0.08 / AQ_t-1 0.07) |
| SGI: 0.99 (Revenue 1.29b / 1.30b) |
| TATA: -0.02 (NI 686.3m - CFO 826.5m) / TA 7.57b) |
| Beneish M = -2.01 (Cap -4..+1) = BB |
As of June 24, 2026, the stock is trading at USD 59.78 with a total of 362,696 shares traded. Over the past week, the price has changed by +2.71%, over one month by -0.44%, over three months by +4.29% and over the past year by +0.02%.
Current recommended Stop Loss: 57.80 (which is 3.3% or 1.5 ATR below the current price).
Essent has received a consensus analysts rating of 3.88. Therefore, it is recommended to buy ESNT.
- StrongBuy: 2
- Buy: 3
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 67.8 | 13.3% |
P/E Trailing = 8.4808
P/E Forward = 8.2508
P/S = 4.2942
P/B = 0.9645
P/EG = 0.84
Revenue TTM = 1.29b USD
EBIT TTM = 854.3m USD
EBITDA TTM = 859.4m USD
Long Term Debt = 495.6m USD (from longTermDebt, last quarter)
Short Term Debt = 5.98m USD (from shortTermDebt, last fiscal year)
Debt = 495.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -5.68b USD (calculated: Debt 495.6m - CCE 6.18b)
Enterprise Value = 5.49b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 26.13 (Ebit TTM 854.3m / Interest Expense TTM 32.7m)
EV/FCF = 6.71x (Enterprise Value 5.49b / FCF TTM 818.6m)
FCF Yield = 14.90% (FCF TTM 818.6m / Enterprise Value 5.49b)
FCF Margin = 63.61% (FCF TTM 818.6m / Revenue TTM 1.29b)
Net Margin = 53.34% (Net Income TTM 686.3m / Revenue TTM 1.29b)
Gross Margin = 87.08% ((Revenue TTM 1.29b - Cost of Revenue TTM 166.3m) / Revenue TTM)
Gross Margin QoQ = 85.37% (prev 82.05%)
Tobins Q-Ratio = 0.73 (Enterprise Value 5.49b / Total Assets 7.57b)
Interest Expense / Debt = 6.60% (Interest Expense 32.7m / Debt 495.6m)
Taxrate = 16.46% (135.3m / 821.6m)
NOPAT = 713.6m (EBIT 854.3m * (1 - 16.46%))
Current Ratio = 5.91 (Total Current Assets 6.88b / Total Current Liabilities 1.16b)
Debt / Equity = 0.09 (Debt 495.6m / totalStockholderEquity, last quarter 5.70b)
Debt / EBITDA = -6.61 (Net Debt -5.68b / EBITDA 859.4m)
Debt / FCF = -6.94 (Net Debt -5.68b / FCF TTM 818.6m)
Total Stockholder Equity = 5.72b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.29% (Net Income 686.3m / Total Assets 7.57b)
RoE = 12.01% (Net Income TTM 686.3m / Total Stockholder Equity 5.72b)
RoCE = 13.75% (EBIT 854.3m / Capital Employed (Equity 5.72b + L.T.Debt 495.6m))
RoIC = 11.24% (NOPAT 713.6m / Invested Capital 6.35b)
WACC = 6.92% (E(5.49b)/V(5.99b) * Re(7.05%) + D(495.6m)/V(5.99b) * Rd(6.60%) * (1-Tc(0.16)))
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -91.11 | Cagr: -5.27%
[DCF] Terminal Value 74.87% ; FCFF base≈832.6m ; Y1≈807.3m ; Y5≈797.4m
[DCF] Fair Price = 197.3 (EV 12.5b - Net Debt -5.68b = Equity 18.2b / Shares 92.2m; r=8.35% [WACC [floored]]; 5y FCF grow -4.11% → 2.50% )
EPS Correlation: 84.78 | EPS CAGR: 3.91% | SUE: 0.47 | # QB: 0
Revenue Correlation: 89.81 | Revenue CAGR: 9.56% | SUE: 0.68 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.78 | Chg30d=-2.28% | Revisions=-50% | Analysts=7
EPS next Quarter (2026-09-30): EPS=1.83 | Chg30d=-0.07% | Revisions=+0% | Analysts=7
EPS current Year (2026-12-31): EPS=7.23 | Chg30d=+0.70% | Revisions=+50% | GrowthEPS=+4.8% | GrowthRev=+9.0%
EPS next Year (2027-12-31): EPS=7.72 | Chg30d=-0.34% | Revisions=+14% | GrowthEPS=+6.8% | GrowthRev=+7.0%
[Analyst] Revisions Ratio: -50%